A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine

Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human immunodeficiency virus (HIV) infection but selects for NVP-resistant virus, which compromises subsequent NVP-based therapy. A 1-week “tail” of lamivudine and zidovudine after SD-NVP decreases the risk o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Van Dyke, Russell B., Ngo-Giang-Huong, Nicole, Shapiro, David E., Frenkel, Lisa, Britto, Paula, Roongpisuthipong, Anuvat, Beck, Ingrid A., Yuthavisuthi, Praparb, Prommas, Sinart, Puthanakit, Thanyawee, Achalapong, Jullapong, Chotivanich, Nantasak, Rasri, Wirawan, Cressey, Tim R., Maupin, Robert, Mirochnick, Mark, Jourdain, Gonzague
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2012
Assuntos:
HIV/AIDS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3245730/
https://ncbi.nlm.nih.gov/pubmed/22144539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cir798
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares